好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Exploring the Link between Fasting Triglyceride Levels and Stroke Infarct Volume
Cerebrovascular Disease and Interventional Neurology
S8 - Disparities and Outcomes in Cerebrovascular Disease (5:06 PM-5:18 PM)
009

Larger infarct volume is known to be predictive of poor stroke outcomes. While some studies suggest a correlation between elevated triglycerides and increased stroke risk, others propose a protective role of triglycerides during acute stroke in terms of severity and three months outcomes. However, the effect of fasting triglyceride levels on infarct volume is not well established.

To analyze the association between fasting triglyceride levels and Computed Tomography Perfusion (CTP) infarct volume in acute ischemic stroke (AIS).

We did a retrospective analysis of AIS patients admitted to a tertiary care United States center from 2010 to 2023. Inclusion criteria were AIS patients who within 24 hours of onset (1) underwent CTP and (2) had fasting triglyceride levels measured. Infarct volume was calculated using RAPID software (iSchemaView, Inc.) Statistical analyses were conducted using STATA (Release 16), with T-tests, ANOVA, chi-square tests, and multivariable linear regression applied as appropriate.

We included 178 patients, 52% (n = 92) of whom were male, with mean age of 67±4.0 years. Mean triglyceride levels were 116.91 ± 70.23 mg/dL, and mean infarct volume was 41.64 ± 53.35 mL. Linear regression showed that triglyceride levels and infarct volume had a significant positive correlation (p < 0.01, β = 0.17, 95% CI: 0.06–0.28). There was a 0.17 mL increase in infarct volume per unit increase in triglyceride levels. Embolic stroke of undetermined source (ESUS) patients had the highest mean triglyceride levels (135.61 mg/dL) and larger infarct volumes compared to those with large artery atherosclerosis (p < 0.05).

We found that hypertriglyceridemia positively correlated with larger infarct volumes, especially in ESUS patients. Our study raises an important question as to whether triglycerides need to be targeted for stroke prevention along with Low Density Lipoproteins (LDL) and glycated hemoglobin (A1C). Future studies are needed to further investigate this potential link.

Authors/Disclosures
Surabhi A. Garg, MD (St Johns Medical College and Hospital)
PRESENTER
Dr. Garg has nothing to disclose.
Tuqa Asedi, MD Dr. Asedi has nothing to disclose.
Elyse Vetter, BA Miss Vetter has nothing to disclose.
Hussein Alsadi (University of Kansas Medical Center) Hussein Alsadi has nothing to disclose.
Rachel A. Dukes, Medical Student Ms. Dukes has nothing to disclose.
Chelsey M. Schartz Ms. Schartz has nothing to disclose.
Mohammed Qussay Ali Al-Sabbagh, MD (University of Kansas Medical Center) Dr. Al-Sabbagh has nothing to disclose.
Sibi Thirunavukkarasu, MD Dr. Thirunavukkarasu has nothing to disclose.
Prasanna Venkatesan Eswaradass, MD (University of Kansas Health System) Dr. Eswaradass has nothing to disclose.